products     news     technology     partners     about us     careers     contact us     home   
 
 
pharmaceutical
homeland security
forensics
medical diagnostics
analytical chemistry
support & performance

 

 

30 November 2020

New production facility to revolutionise Raman spectroscopy.

The first ever production facility dedicated to the manufacture of surface enhanced Raman spectroscopy (SERS) substrates has opened in Southampton, UK. The facility, which is a 1/4 million investment by Mesophotonics Ltd., has been built in response to customer demand for the company’s Klarite substrates launched earlier this year. One million times more effective than traditional lab-generated Raman substrates, Klarite offers very high levels of sensitivity, reliability and reproducibility and is already being used in more than 150 academic and industrial laboratories worldwide.

“Klarite signifies a major step forward in Raman spectroscopy,” explains Professor Michael Morris at the University of, who is using Klarite in his SERS-based research on early identification of biomarkers for osteoarthritis. “It can finally become the pioneering analytical tool that it promised to be when first developed thirty years ago.”

As well as its role in medical research, specifically drug discovery and production, Klarite’s ability to enable faster, higher accuracy analysis of biological and chemical samples at lower detection limits also makes it ideal for applications in forensics and homeland security.

We are delighted that Klarite has already had such a significant impact,” comments James McKenzie, CEO of Mesophotonics. “And the new facility ensures all organisations can now access this exciting new technology quickly and easily.”

Klarite has been designed for use with existing Raman instruments and its high sensitivity means users can get meaningful, repeatable results even with lower cost instrumentation. As a result, SERS research has now become an affordable analytical process for both small and large organisations.